VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Novo Nordisk A/S vs The Charles Schwab Corporation
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisThe Charles Schwab Corporation
SCHW · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into The Charles Schwab Corporation's moat claims, evidence, and risks.
View SCHW analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 74 / 100 for The Charles Schwab Corporation).
- Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); The Charles Schwab Corporation has 2 segments (79.4% in Investor Services).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Weak.
- Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; The Charles Schwab Corporation has 7 across 4.
Primary market context
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
The Charles Schwab Corporation
Investor Services
U.S. retail brokerage, self-directed investing, and wealth management platforms
United States
Retail investors, employers, retirement plan sponsors
Broker-dealer + bank + wealth manager platform
79.4%
Side-by-side metrics
Moat coverage
Shared moat types
Novo Nordisk A/S strengths
The Charles Schwab Corporation strengths
Segment mix
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
The Charles Schwab Corporation segments
Full profile >Investor Services
Oligopoly
Advisor Services
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.